Yahong Pharmaceuticals (688176.SH) has newly identified Sun Longwei and Sun Qiaoling as core technical personnel.

Yuhong Pharmaceuticals (688176.SH) announced that Mr. YUSHEN GUO, a core technical personnel of the company, has reached retirement age and will no longer serve in a management position. The company will continue to employ Mr. YUSHEN GUO as a senior technical consultant through re-employment, providing technical guidance and advice on the development and improvement of the company's research and development technology. Mr. YIJUN DENG, another core technical personnel, will focus on pipeline development in the anti-infection field at subsidiary MetCura Pharmaceuticals Inc. Due to these adjustments, the guidance and management provided by Mr. YUSHEN GUO and Mr. YIJUN DENG on the research and development of core technical products of the company will be reduced, and therefore they will no longer be recognized as core technical personnel of the company. These adjustments will not have a significant adverse impact on the company's technical research and production operations, and will not affect the company's ownership of core technology. In consideration of the employment history of Mr. Sun Longwei and Ms. Sun Qiaoling, as well as their participation in the company's core technical research and their roles, the company has newly recognized them as core technical personnel.